We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-10.54%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$129B
AUM Growth
-$14.8B
Cap. Flow
+$5.69B
Cap. Flow %
4.39%
Top 10 Hldgs %
31.86%
Holding
7,834
New
489
Increased
2,471
Reduced
3,566
Closed
777

Sector Composition

Rank Sector Weight
1 Technology 6.9%
2 Healthcare 5.31%
3 Financials 5.25%
4 Communication Services 4.61%
5 Consumer Discretionary 4.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
6101
PUT
LKQ Corp
LKQ
$6.29B
$9K ﹤0.01%
+400
New +$10.9K
LOCO icon
6102
PUT
El Pollo Loco
LOCO
$462M
$9K ﹤0.01%
600
-3,200
-84% -$46.1K
LRMR icon
6103
Larimar Therapeutics
LRMR
$432M
$9K ﹤0.01%
152
-801
-84% -$79.1K
MBIN icon
6104
Merchants Bancorp
MBIN
$2.49B
$9K ﹤0.01%
662
-8,901
-93% -$134K
MIDU icon
6105
Direxion Daily Mid Cap Bull 3X ETF
MIDU
$79.4M
$9K ﹤0.01%
335
+200
+148% +$7.78K
NEWT icon
6106
NewtekOne
NEWT
$391M
$9K ﹤0.01%
532
-8,795
-94% -$170K
PFIS icon
6107
Peoples Financial Services
PFIS
$707M
$9K ﹤0.01%
199
-2,665
-93% -$113K
RCKY icon
6108
Rocky Brands
RCKY
$369M
$9K ﹤0.01%
348
-3,221
-90% -$83.2K
RES icon
6109
CALL
RPC Inc
RES
$1.3B
$9K ﹤0.01%
900
-1,200
-57% -$16.3K
RILY icon
6110
BRC Group Holdings
RILY
$289M
$9K ﹤0.01%
694
-8,488
-92% -$156K
RSP icon
6111
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$9K ﹤0.01%
100
SMBC icon
6112
Southern Missouri Bancorp
SMBC
$850M
$9K ﹤0.01%
282
-2,746
-91% -$95.4K
STRO icon
6113
Sutro Biopharma
STRO
$421M
$9K ﹤0.01%
+100
New +$12.1K
MDRX
6114
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
$9K ﹤0.01%
+900
New +$10K
SFE
6115
PUT
DELISTED
Safeguard Scientifics, Inc.
SFE
$9K ﹤0.01%
+1,000
New +$8.72K
APRN
6116
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$9K ﹤0.01%
46
-2,565
-98% -$544K
FRBK
6117
DELISTED
Republic First Bancorp Inc
FRBK
$9K ﹤0.01%
1,412
-22,404
-94% -$151K
ACOR
6118
PUT
DELISTED
Acorda Therapeutics
ACOR
$9K ﹤0.01%
+5
New +$10.9K
FRC
6119
CALL
DELISTED
First Republic Bank
FRC
$9K ﹤0.01%
100
-1,000
-91% -$91.3K
VIVO
6120
CALL
DELISTED
Meridian Bioscience Inc
VIVO
$9K ﹤0.01%
500
+200
+67% +$3.41K
NH
6121
DELISTED
NantHealth, Inc
NH
$9K ﹤0.01%
1,101
+321
+41% +$5.62K
DLPH
6122
PUT
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$9K ﹤0.01%
660
-363
-35% -$7.07K
NTGN
6123
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$9K ﹤0.01%
1,747
-2,362
-57% -$16.5K
TSG
6124
DELISTED
The Stars Group Inc.
TSG
$9K ﹤0.01%
575
-10,863
-95% -$212K
CRR
6125
PUT
DELISTED
Carbo Ceramics Inc.
CRR
$9K ﹤0.01%
2,600
+2,400
+1,200% +$12K

Similar funds

Barclays's Q4 2018 Portfolio in Review

As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.

  • Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
  • Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
  • Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
  • Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
  • Barclays opened 489 new positions and closed 777 in Q4 2018.
  • Barclays's portfolio value fell 10% quarter-over-quarter to $129B.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.